Blog
890 Articles
A Novel Combination to Slow Pancreas Tumors that Cannot Be Surgically Removed
Can a combination of standard drugs, a PARP inhibitor, and intensity modulated radiation therapy to slow pancreatic tumor growth?
With No Family History of Cancer, Surprised By the Diagnosis
Marianne, a nurse, went to a hospital that specializes in cancer. A liquid biopsy will determine the next step in her treatment.
Pancreatic Cancer Tissue Helps Unlock the Disease’s Secrets
Dr. Christine Iacobuzio-Donahue at Memorial Sloan Kettering is using techniques from evolutionary biology to learn how pancreatic cancer grows.
High-Dose Focused Radiation after Surgical Removal of Pancreatic Tumors
A clinical trial looks at the effectiveness of stereotactic body radiation therapy in killing cancer cells in the margins after pancreatic tumor removal.
Going Place-to-Place to Find the Treatments I Wanted
David Shell traveled around to a number of doctors and hospitals at different stages of his treatment to be able to get surgery to remove his tumor.
New Drug Shows Positive Results in Early Trials
A new drug called PEGPH20, which helps chemotherapy drugs reach their target, is showing positive results in an ongoing pancreatic cancer trial.
Slowing the Growth of Pancreatic Tumors Before Surgery
A chemoradiation clinical trial tests standard chemotherapy plus an anti-malaria drug and compares two types of radiation treatments, to slow tumor growth.
Living with Pancreatic Cancer
Camille Altgelt searched for clinical trials for her pancreatic cancer but did not qualify. Her treatment with chemotherapy and radiation was successful.
A New Chemotherapy and Radiation Regimen to Shrink Tumors Before Surgery
Researchers are testing a new combination of chemotherapies and radiation to shrink pancreatic cancer tumors and make surgical removal possible.
Making a Risky Choice
Judith Zitiello’s pancreatic cancer was wrapped around the hepatic artery, but she chose the laparoscopic Whipple procedure instead of chemotherapy alone.
Solving the Mystery of Cachexia
Researchers are looking for ways to combat cachexia, the metabolic syndrome that causes weight and muscle loss in people with cancer and other diseases.
Exploring the Effectiveness of an Experimental Class of Drug
Does adding a PARP inhibitor drug to standard treatment help control the spread of advanced pancreatic cancer in patients with the BRCA mutation?
The Impact of BRCA Is Broader Than Breast and Ovarian Cancer
Rona Greenberg discusses the impact of BRCA2 on her family, and her search for the best clinical trial for her needs after her pancreatic cancer diagnosis.
Using a Colon Cancer Drug to Treat Advanced Pancreatic Cancer
A clinical trial tests the effectiveness of an approved colon cancer drug against advanced pancreatic neuroendocrine cancer.
Working With your Doctor to Find Clinical Trials
Oncologist Dr. Kim A. Reiss explains the importance of clinical trials and family history of cancer when choosing a treatment for pancreatic cancer.